Shorla Oncology is a pharmaceutical company focused on developing innovative oncology products to address unmet clinical needs. The company aims to improve patient care by providing therapies that are easier to administer and have the potential to reduce side effects.

At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.

COM:SHORLAONCOLOGY

Shorla Oncology

Analysis Not Available